Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Attention Deficit Hyperactivity Disorder Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Attention Deficit Hyperactivity Disorder Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Stimulants Drugs
      • 1.3.3 Non-stimulants Drugs
    • 1.4 Market Segment by Application
      • 1.4.1 Global Attention Deficit Hyperactivity Disorder Market Share by Application (2019-2025)
      • 1.4.2 Pediatric
      • 1.4.3 Adolescent
      • 1.4.4 Adults
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Attention Deficit Hyperactivity Disorder Market Size
      • 2.1.1 Global Attention Deficit Hyperactivity Disorder Revenue 2014-2025
      • 2.1.2 Global Attention Deficit Hyperactivity Disorder Sales 2014-2025
    • 2.2 Attention Deficit Hyperactivity Disorder Growth Rate by Regions
      • 2.2.1 Global Attention Deficit Hyperactivity Disorder Sales by Regions 2014-2019
      • 2.2.2 Global Attention Deficit Hyperactivity Disorder Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Attention Deficit Hyperactivity Disorder Sales by Manufacturers
      • 3.1.1 Attention Deficit Hyperactivity Disorder Sales by Manufacturers 2014-2019
      • 3.1.2 Attention Deficit Hyperactivity Disorder Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Attention Deficit Hyperactivity Disorder Revenue by Manufacturers (2014-2019)
      • 3.2.2 Attention Deficit Hyperactivity Disorder Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Attention Deficit Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)
    • 3.3 Attention Deficit Hyperactivity Disorder Price by Manufacturers
    • 3.4 Key Manufacturers Attention Deficit Hyperactivity Disorder Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Attention Deficit Hyperactivity Disorder Market
    • 3.6 Key Manufacturers Attention Deficit Hyperactivity Disorder Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Stimulants Drugs Sales and Revenue (2014-2019)
      • 4.1.2 Non-stimulants Drugs Sales and Revenue (2014-2019)
    • 4.2 Global Attention Deficit Hyperactivity Disorder Sales Market Share by Type
    • 4.3 Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Type
    • 4.4 Attention Deficit Hyperactivity Disorder Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Attention Deficit Hyperactivity Disorder Sales by Application

    6 United States

    • 6.1 United States Attention Deficit Hyperactivity Disorder Breakdown Data by Company
    • 6.2 United States Attention Deficit Hyperactivity Disorder Breakdown Data by Type
    • 6.3 United States Attention Deficit Hyperactivity Disorder Breakdown Data by Application

    7 European Union

    • 7.1 European Union Attention Deficit Hyperactivity Disorder Breakdown Data by Company
    • 7.2 European Union Attention Deficit Hyperactivity Disorder Breakdown Data by Type
    • 7.3 European Union Attention Deficit Hyperactivity Disorder Breakdown Data by Application

    8 China

    • 8.1 China Attention Deficit Hyperactivity Disorder Breakdown Data by Company
    • 8.2 China Attention Deficit Hyperactivity Disorder Breakdown Data by Type
    • 8.3 China Attention Deficit Hyperactivity Disorder Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Attention Deficit Hyperactivity Disorder Breakdown Data by Company
    • 9.2 Rest of World Attention Deficit Hyperactivity Disorder Breakdown Data by Type
    • 9.3 Rest of World Attention Deficit Hyperactivity Disorder Breakdown Data by Application
    • 9.4 Rest of World Attention Deficit Hyperactivity Disorder Breakdown Data by Countries
      • 9.4.1 Rest of World Attention Deficit Hyperactivity Disorder Sales by Countries
      • 9.4.2 Rest of World Attention Deficit Hyperactivity Disorder Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Eli Lilly
      • 10.1.1 Eli Lilly Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.1.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.1.5 Eli Lilly Recent Development
    • 10.2 Novartis
      • 10.2.1 Novartis Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.2.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.2.5 Novartis Recent Development
    • 10.3 Shire
      • 10.3.1 Shire Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.3.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.3.5 Shire Recent Development
    • 10.4 Pfizer
      • 10.4.1 Pfizer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.4.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.4.5 Pfizer Recent Development
    • 10.5 GlaxoSmithKline
      • 10.5.1 GlaxoSmithKline Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.5.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.5.5 GlaxoSmithKline Recent Development
    • 10.6 Mallinckrodt
      • 10.6.1 Mallinckrodt Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.6.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.6.5 Mallinckrodt Recent Development
    • 10.7 Hisamitsu
      • 10.7.1 Hisamitsu Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.7.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.7.5 Hisamitsu Recent Development
    • 10.8 Impax
      • 10.8.1 Impax Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.8.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.8.5 Impax Recent Development
    • 10.9 Johnson & Johnson
      • 10.9.1 Johnson & Johnson Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.9.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.9.5 Johnson & Johnson Recent Development
    • 10.10 UCB
      • 10.10.1 UCB Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Attention Deficit Hyperactivity Disorder
      • 10.10.4 Attention Deficit Hyperactivity Disorder Product Introduction
      • 10.10.5 UCB Recent Development
    • 10.11 Purdue Parma

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Attention Deficit Hyperactivity Disorder Sales Channels
      • 11.2.2 Attention Deficit Hyperactivity Disorder Distributors
    • 11.3 Attention Deficit Hyperactivity Disorder Customers

    12 Market Forecast

    • 12.1 Global Attention Deficit Hyperactivity Disorder Sales and Revenue Forecast 2019-2025
    • 12.2 Global Attention Deficit Hyperactivity Disorder Sales Forecast by Type
    • 12.3 Global Attention Deficit Hyperactivity Disorder Sales Forecast by Application
    • 12.4 Attention Deficit Hyperactivity Disorder Forecast by Regions
      • 12.4.1 Global Attention Deficit Hyperactivity Disorder Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Attention Deficit Hyperactivity Disorder Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      ADHD is a brain/neurodevelopmental/neurobehavioral disorder characterized by pervasive and impairing symptoms of inattention, hyperactivity, and impulsivity. The Centers for Disease Control and Prevention (CDC) defines “neurobehavioral” as the way the brain affects emotion, behavior, and learning.
      In 2019, the market size of Attention Deficit Hyperactivity Disorder is 16800 million US$ and it will reach 27100 million US$ in 2025, growing at a CAGR of 6.2% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Attention Deficit Hyperactivity Disorder.

      This report studies the global market size of Attention Deficit Hyperactivity Disorder, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Attention Deficit Hyperactivity Disorder sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Eli Lilly
      Novartis
      Shire
      Pfizer
      GlaxoSmithKline
      Mallinckrodt
      Hisamitsu
      Impax
      Johnson & Johnson
      UCB
      Purdue Parma

      Market Segment by Product Type
      Stimulants Drugs
      Non-stimulants Drugs

      Market Segment by Application
      Pediatric
      Adolescent
      Adults

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Attention Deficit Hyperactivity Disorder status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Attention Deficit Hyperactivity Disorder manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Attention Deficit Hyperactivity Disorder are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now